결체 조직 질환에서의 흉막 삼출 = Special Review : Pleural Effusion in Connective Tissue Diseases

다국어 초록 (Multilingual Abstract)

Connective tissue diseases represent an heterogenous group of immunologically mediated inflammatory disorders including multiorgan involvement, can affect pleura with various frequencies. Rheumatoid arthritis and systemic lupus erythematosus represent the most common immunological diseases that affect the pleural cavity. The clinical presentation, frequency, prognosis and response to therapy vary, depending on the pattern of involvement as well as on the underlying connective tissue diseases. In this article, we will review the pleural effusion caused by connective tissue diseases. (Korean J Med 2011;81:154-160)

참고문헌 (Reference)

1 Blundell AG, "Wegener’'s granulomatosis presenting as a pleural effusion" 327 : 95-96, 2003

2 Diot E, "Wegener’'s disease mimicking acute infectious pleurisy" 56 : 265-268, 2000

3 Miyata M, "Two patients with polymyositis or dermatomyositis complicated with massive pleural ef" 37 : 1058-1063, 1998

4 Sherer Y, "Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin" 8 : 324-327, 1999

5 Breuer GS, "Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature" 34 : 744-749, 2005

6 Crestani B, "The respiratory system in connective tissue disorders" 60 : 715-734, 2005

7 Koster FT, "The mediator of cellular immunity. II: migration of immunologically committed lymphocytes into inflammatory exudates" 133 : 400-409, 1971

8 Haupt HM, "The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients" 71 : 791-798, 1981

9 Amital A, "The lung in rheumatoid arthritis" 40 : e31-e48, 2011

10 McKnight KM, "Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus" 34 : 1483-1484, 1991

11 Balbir-Gurman A, "Rheumatoid pleural effusion" 35 : 368-378, 2006

12 Hakala M, "Rheumatoid arthritis with pleural effusion includes a subgroup with autoimmune features and HLA-B8, Dw3 association" 15 : 290-296, 1986

13 Prakash UB, "Respiratory complications in mixed connective tissue disease" 19 : 733-746, 1998

14 Kaine JL, "Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage" 44 : 61-64, 1985

15 Spencer DG, "Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27" 6 : 305-315, 1979

16 Davies D, "Pyopneumothorax in rheumatoid lung disease" 21 : 230-223, 1966

17 Strimlan CV, "Pulmonary manifestations of Sjögren’'s syndrome" 70 : 354-361, 1976

18 Cheema GS, "Pulmonary involvement in adult-onset Still’'s disease" 5 : 305-309, 1999

19 Brasington RD, "Pulmonary disease in systemic lupus erythematosus" 3 : 269-276, 1985

20 Lakhanpal S, "Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases" 46 : 23-29, 1987

21 Kashiwabara K, "Primary Sjögren’'s syndrome accompanied by pleural effusion" 33 : 1325-1329, 1995

22 Winslow WA, "Pleuritis in systemic lupus erythematosus: its importance as an early manifestation in diagnosis" 49 : 70-88, 1958

23 Kawamata K, "Pleurisy in primary Sjögren’'s syndrome: T cell receptor beta-chain variable region gene bias and local autoantibody production in the pleural effusion" 15 : 193-196, 1997

24 Aiello M, "Pleural involvement in systemic disorders" 3 : 441-447, 2004

25 Bouros D, "Pleural involvement in systemic autoimmune disorders" 75 : 361-371, 2008

26 Hunder GG, "Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis" 76 : 357-363, 1972

27 Highland KB, "Pleural effusion in interstitial lung disease" 10 : 390-396, 2004

28 Bambery P, "Pleural effusion in Wegener’'s granulomatosis: report of five patients and a brief review of the literature" 20 : 445-447, 1991

29 Light RW, "Pleural disease. 3rd ed" Williams & Wilkins 1995

30 Torre O, "Pleural and pulmonary involvement in systemic lupus erythematosus" 40 : e19-e29, 2011

31 Jantz MA, "Pathophysiology of the Pleura" 75 : 121-113, 2008

32 Erkan L, "Isolated pleural and pericardial effusion in a patient with ankylosing spondylitis" 101 : 356-358, 2007

33 Halla JT, "Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases" 92 : 748-752, 1980

34 Mizushima Y, "IgE rheumatoid factor in a case of rheumatoid arthritis with pleuritis" 8 : 299-302, 1981

35 Lee YH, "Exudative pleural effusion and pleural leukocytoclastic vasculitis in limited scleroderma" 25 : 1006-1008, 1998

36 Alexandrakis MG, "Evaluation of inflammatory cytokines in malignant and benign pleural effusions" 7 : 1327-1332, 2000

37 Mattiuzzo M, "Bilateral empyema caused by adult-onset Still’'s disease" 68 : 88-90, 2001

38 Khare V, "Antinuclear antibodies in pleural fluid" 106 : 866-871, 1994

39 Zorab PA, "Ankylosing spondylitis, a note on an early contribution from Guy’'s" 110 : 96-98, 1961

40 Thompson AE, "A study of the frequency of pericardial and pleural effusions in scleroderma" 37 : 1320-1323, 1998

41 Nishio J, "A refractory case of adult-onset Still’'s disease" 20 : 191-198, 1997

42 Sullivan WD, "A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease" 63 : 92-107, 1984

43 Tojima H, "A case of Wegener’'s granulomatosis with episcleritis, mediastinal lesions, and pleural effusion and without serum anti-neutrophil cytoplasmic antibodies" 32 : 62-67, 1994